| Parenteral Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524689 |
NSE Symbol : PDPL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE904D01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -300.60 |
Market Cap(₹Cr) : 10.11 |
Face Value(₹) : 10.00 |
| Particulars | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.02 | 0.02 | 0.44 |
| Net Sales | 12.17 | 31.87 | 33.21 | 32.95 | 52.21 |
| Other Income | 0.06 | 0.25 | 0.24 | 1.34 | 2.53 |
| Stock Adjustments | 0.62 | -1.14 | 1.11 | -1.06 | -3.09 |
| Total Income | 12.85 | 30.98 | 34.56 | 33.23 | 51.65 |
| EXPENDITURE : | |||||
| Raw Materials | 6.28 | 5.18 | 7.57 | 5.70 | 22.94 |
| Power and Fuel Cost | 0.71 | 9.57 | 10.87 | 8.47 | 8.45 |
| Other Manufacturing Expenses | 0.94 | 6.80 | 7.09 | 6.13 | 7.78 |
| Selling and Administration Expenses | 1.76 | 3.60 | 4.70 | 7.93 | 12.55 |
| Miscellaneous Expenses | 0.36 | 1.06 | 0.61 | 2.81 | 16.95 |
| Employee Benefit Expenses | 14.51 | 19.21 | 19.94 | 16.70 | 15.11 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -11.70 | -14.43 | -16.23 | -14.50 | -32.12 |
| Interest | 125.44 | 109.96 | 96.05 | 86.34 | 73.94 |
| Gross Profit | -137.14 | -124.39 | -112.28 | -100.84 | -106.06 |
| Depreciation | 17.33 | 17.35 | 69.12 | 18.57 | 19.10 |
| Profit Before Tax | -154.47 | -141.74 | -181.40 | -119.41 | -125.16 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -32.76 | -27.66 | -33.49 | -23.31 | -11.08 |
| Reported Net Profit | -121.71 | -114.07 | -147.90 | -96.09 | -114.09 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.10 |
| Adjusted Net Profit | -121.71 | -114.07 | -147.90 | -96.09 | -113.99 |
| Adjustment below Net Profit | 0.14 | -0.31 | -0.25 | -0.02 | -0.30 |
| Profit/Loss Balance carried down | -913.41 | -799.02 | -650.87 | -554.75 | -440.36 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -1,034.97 | -913.41 | -799.02 | -650.87 | -554.75 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -40.82 | -38.26 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | -264.89 | -224.12 | -185.75 | -136.07 | -103.83 |
| Book Value(Adj)-Unit Curr | -264.89 | -224.12 | -185.75 | -136.07 | -103.83 |